Literature DB >> 138681

Characterization of the nucleoside triphosphate phosphohydrolase (ATPase) activity of RNA synthesi termination factor p. I. Enzymatic properties and effects of inhibitors.

C Lowery, J P Richardson.   

Abstract

The purification of p protein to homogeneity from Escherichia coli has shown that its RNA-dependent ATPase activity is physically inseparable from its termination activity. The biochemical properties of pATPase have been studied using poly(C) as the activating RNA. This reaction is stimulated by Mg2+ ions and Mn2+ ions and is prevented by excess EDTA; it is not stimulated by Ca2+ ions. The reaction is not affected by a Zn2+ ion chelator and is inhibited by 1 mM Zn2+. With Mg2+ present, the activity is essentially constant from pH 7 to pH 9.7. pATPase is sensitive to p-hydroxymercuribenzoate and to N-ethylmaleimide. All four ribonucleoside triphosphates are hydrolyzed by p action. ATP has the lowest Km (0.009 mM), while CTP has the highest Vmax. In a mixture containing all four nucleoside triphosphates at a concentration of 0.4 mM, p shows no strong preference for any one of the substrates. The response of p ATPase to a variety of inhibitors of other ATPases and GTPases and of transcription has been studied. Of the compounds tested, aurintricarboxylic acid, an inhibitor of protein-nucleic acid interactions, was found to be a potent inhibitor of p ATPase, while rifampicin and heparin had no effect. pATPase showed partial sensitivity to thiostrepton, fusidic acid, Dio 9, and sodium azide.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 138681

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Functional interactions of ligand cofactors with Escherichia coli transcription termination factor rho. II. Binding of RNA.

Authors:  J Geiselmann; T D Yager; P H von Hippel
Journal:  Protein Sci       Date:  1992-07       Impact factor: 6.725

2.  The Elongator subcomplex Elp456 is a hexameric RecA-like ATPase.

Authors:  Sebastian Glatt; Juliette Létoquart; Céline Faux; Nicholas M I Taylor; Bertrand Séraphin; Christoph W Müller
Journal:  Nat Struct Mol Biol       Date:  2012-02-19       Impact factor: 15.369

3.  Cell-free translation of purified virion-associated high-molecular-weight RNA synthesized in vitro by vaccinia virus.

Authors:  W Bossart; E Paoletti; D L Nuss
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

4.  The transcription termination factor Rho is essential and autoregulated in Caulobacter crescentus.

Authors:  Valéria C S Italiani; Marilis V Marques
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

5.  Functional interactions of ligand cofactors with Escherichia coli transcription termination factor rho. I. Binding of ATP.

Authors:  J Geiselmann; P H von Hippel
Journal:  Protein Sci       Date:  1992-07       Impact factor: 6.725

6.  Characterization of a ribonuclease-sensitive nucleoside triphosphatase activity from HeLa nuclei.

Authors:  L V Richardson; J P Richardson
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

7.  Escherichia coli transcription termination factor rho has a two-domain structure in its activated form.

Authors:  D G Bear; C L Andrews; J D Singer; W D Morgan; R A Grant; P H von Hippel; T Platt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

8.  Pyrophosphate inhibition of rho ATPase: a mechanism of coupling to RNA polymerase activity.

Authors:  R B Kent; S K Guterman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

9.  Steady state kinetic studies of initiation of RNA synthesis on T7 DNA in the presence of rifampicin.

Authors:  J W Smagowicz; K H Scheit
Journal:  Nucleic Acids Res       Date:  1977-11       Impact factor: 16.971

10.  Rifampicin supersensitivity of rho strains of E. coli, and suppression by sur mutation.

Authors:  S K Guterman; C L Howitt
Journal:  Mol Gen Genet       Date:  1979-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.